Table 3. Changes in physical function in the two groups.

		Δ12 weeks				Time effect	Time*treatment interaction
		Novel supplement (n=40)	P-value	Standard supplement (n=41)	P-valuea
Walking performance	4 mb	-0.4 ± 0.1 s	0.047	0.0 ± 0.1 s	1.000	0.044	0.048
	400 mc	-7.4 ± 8.7 s	1.000	17.6 ± 7.8 s	0.172	0.386	0.038
Handgrip Strengthb	Dom	0 ± 1 kg	1.000	0 ± 1 kg	1.000	0.974	0.948
	Non-dom	0 ± 1 kg	1.000	1 ± 1 kg	1.000	0.660	0.340
Knee extensiond	Dom	-2 ± 14 N	1.000	26 ± 21 N	1.000	0.200	0.145
	Non-dom	8 ± 12 N	1.000	38 ± 10 N	0.003	0.005	0.058
Knee flexiond	Dom	12 ± 9 N	1.000	23 ± 8 N	0.036	0.006	0.351
	Non-dom	6 ± 10 N	1.000	15 ± 8 N	0.443	0.106	0.453
Chair rise testc		0.0 ± 0.5 s	1.000	-0.3 ± 0.4 s	1.000	0.543	0.634
SPPB score		0.1 ± 0.2 pt	1.000	0.3 ± 0.2 pt	0.523	0.169	0.355

Dom, dominant limb; non-dom, non-dominant limb; N, Newton; SPPB, short physical performance battery.

^aP-values are from posthoc tests with Bonferroni adjustment of multiple testing.

^bAdjusted for gender and height.

^cAdjusted for gender, height and age.

^dAdjusted for gender, height, age and observer.